BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22437781)

  • 1. siRNA delivery: Loaded-up microsponges.
    Grabow WW; Jaeger L
    Nat Mater; 2012 Mar; 11(4):268-9. PubMed ID: 22437781
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-assembled RNA interference microsponges for efficient siRNA delivery.
    Lee JB; Hong J; Bonner DK; Poon Z; Hammond PT
    Nat Mater; 2012 Feb; 11(4):316-22. PubMed ID: 22367004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted siRNA Delivery Using Lipid Nanoparticles.
    Jorge A; Pais A; Vitorino C
    Methods Mol Biol; 2020; 2059():259-283. PubMed ID: 31435927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
    Howard KA; Kjems J
    Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine as a promising vector for targeted siRNA delivery.
    Nimesh S
    Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
    Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
    Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silicon particles for sustained gene silencing.
    Hasan N; Mann A; Ferrari M; Tanaka T
    Methods Mol Biol; 2013; 1049():481-93. PubMed ID: 23913239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of siRNAs.
    Lamberti G
    Int J Pharm; 2017 Jun; 525(2):291-292. PubMed ID: 28535902
    [No Abstract]   [Full Text] [Related]  

  • 13. Research progress on siRNA delivery with nonviral carriers.
    Gao Y; Liu XL; Li XR
    Int J Nanomedicine; 2011; 6():1017-25. PubMed ID: 21720513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of siRNA into the blood-brain barrier: recent advances and future perspective.
    Kuwahara H; Yokota T
    Ther Deliv; 2012 Apr; 3(4):417-20. PubMed ID: 22834073
    [No Abstract]   [Full Text] [Related]  

  • 15. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
    Lieberman J; Song E; Lee SK; Shankar P
    Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
    Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
    J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
    Mehrotra N; Tripathi RM
    IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
    Li J; Wu C; Wang W; He Y; Elkayam E; Joshua-Tor L; Hammond PT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2696-E2705. PubMed ID: 29432194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.
    Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S
    Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.